ReviewJournal of assisted reproduction and genetics2025
Exploring the epigenetic mechanisms of recurrent pregnancy loss: from genetic predisposition to environmental influences.
Review in Journal of assisted reproduction and genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Recurrent pregnancy loss (RPL) is a complex and emotionally distressing condition defined by the occurrence of two or more consecutive miscarriages before 20 weeks of gestation. The exact causes of RPL remain unclear, despite extensive research into its genetic, immune, and environmental underpinnings. Recent advances in epigenetics have revealed that alterations in DNA methylation, histone modifications, and non-coding RNA expression play crucial roles in regulating pregnancy-related processes such as immune tolerance, placental development, and embryo implantation. These epigenetic changes are influenced not only by genetic predisposition but also by environmental factors, highlighting the dynamic interaction between genes and the environment in the pathogenesis of RPL. This review explores the role of epigenetics in RPL, focusing on the identification of epigenetic biomarkers, their potential for early diagnosis and prediction, and their implications for targeted therapeutic interventions. We also discuss how environmental factors, including diet, stress, and pollutants, can modify epigenetic regulation, potentially increasing the risk of RPL. Furthermore, emerging epigenetic-based therapies, such as epigenetic drugs and gene editing, are discussed as potential approaches to improving pregnancy outcomes in women with RPL. This review underscores the need for further research to translate epigenetic findings into clinical applications for personalized and precision medicine in RPL management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.